Peiling Zhang
Liver Cancer Institute And Key Laboratory Of Carcinogenesis And Cancer Invasion Of The Ministry Of Education
Zhongshan, China
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
HKDC1-mediated polyamine rewiring drives lenvatinib resistance and immune escape in hepatocellular carcinoma.
Journal: Clinical and molecular hepatology
Published: November 09, 2025
Automating classification of treatment responses to combined targeted therapy and immunotherapy in HCC.
Journal: Journal of molecular cell biology
Published: May 29, 2025
Hypoxia-related CircARSB Modulates lipid metabolism and innate immune crosstalk to influence immune checkpoint inhibitor response in hepatocellular carcinoma.
Journal: Cancer letters
Published: May 02, 2025
KPNA2 silencing sensitizes triple-negative breast cancer to chemotherapy by promoting multipolar division and suppressing DNA damage repair.
Journal: Oncogene
Published: February 02, 2025
GALNT6 drives lenvatinib resistance in hepatocellular carcinoma through autophagy and cancer-associated fibroblast activation.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: December 19, 2024
Lactylation-Driven NUPR1 Promotes Immunosuppression of Tumor-Infiltrating Macrophages in Hepatocellular Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 17, 2024
Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma.
Journal: Cellular & molecular immunology
Published: April 18, 2024
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma.
Journal: Cancer communications (London, England)
Published: December 31, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026